← Back to Search

Cannabinoid

CBD Oral Solution for Social Anxiety Disorder

Phase 2
Waitlist Available
Research Sponsored by EmpowerPharm Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial is testing whether CBD can help people with Social Anxiety Disorder (SAD). The study will compare two different doses of CBD to see which works best. CBD might help reduce anxiety by calming the brain. Cannabidiol (CBD) has shown anxiolytic effects in both humans and animals, and has been tested in various clinical trials for anxiety disorders.

Eligible Conditions
  • Social Anxiety Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Cannabidiol (CBD) Oral Solution 600 mg/dayExperimental Treatment1 Intervention
Group II: Cannabidiol (CBD) Oral Solution 300 mg/dayExperimental Treatment1 Intervention
Group III: Placebo Oral SolutionPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cannabidiol oral solution
2022
Completed Phase 2
~240

Find a Location

Who is running the clinical trial?

EmpowerPharm Inc.Lead Sponsor
~84 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top